Adverse association between obesity and menopause in mice treated with bezafibrate, a pan peroxisome proliferator-activated receptor agonist

Menopause

Volumn 20, Issue 12, 2013, Pages 1264-1274

  Da Silva Faria, Tatiane ^a   Correia Junior, Antonio Ludgero ^a   Dos Anjos, Thabata Lessa ^a   Aguila, Marcia Barbosa ^a   Mandarim De Lacerda, Carlos Alberto ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

GLUT2; High fat diet; Insulin resistance; Islet hypertrophy; Ovariectomy

Indexed keywords

BEZAFIBRATE; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; C57BL 6 MOUSE; CALORIC INTAKE; CELL VOLUME; CONTROLLED STUDY; CYTOLOGY; DIET RESTRICTION; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL OF ASSESSMENT; HYPERTROPHY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MENOPAUSE; METABOLISM; MORPHOMETRICS; MOUSE; NONHUMAN; OBESITY; OVARIECTOMY; PANCREAS FUNCTION; PANCREAS FUNCTION TEST; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; STEREOLOGY; UTERUS; VAGINA;

ADIPOSITY; ANIMALS; BEZAFIBRATE; DIET, HIGH-FAT; FEMALE; HYPOLIPIDEMIC AGENTS; ISLETS OF LANGERHANS; MENOPAUSE; MICE; MICE, INBRED C57BL; OBESITY; OVARIECTOMY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 84889082574     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31828f5e3c     Document Type: Article

References (58)

1. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007; 17:319-326. (Pubitemid 46551691)
2. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212-223.
3. Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 2010;34:396-400.
4. Zhao F, Williams M, Meng X, et al. Pain fMRI in rat cervical spinal cord: an echo planar imaging evaluation of sensitivity of BOLD and blood volume-weighted fMRI. Neuroimage 2009;44:349-362.
5. Barbosa-da-Silva S, Fraulob-Aquino JC, Lopes JR, Mandarim-de-Lacerda CA, Aguila MB. Weight cycling enhances adipose tissue inflammatory responses in male mice. PLoS One 2012;7:e39837.
6. Catta-Preta M, Martins MA, Cunha Brunini TM, Mendes-Ribeiro AC, Mandarim-de-Lacerda CA, Aguila MB. Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets. Nutrition 2012;28:212-219.
7. Matveyenko AV, Gurlo T, Daval M, Butler AE, Butler PC. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced β-cell endoplasmic reticulum stress. Diabetes 2009;58:906-916.
8. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.
9. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-4170.
10. Ludgero-Correia A Jr, Aguila MB, Mandarim-de-Lacerda CA, Faria TS. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition 2012;28: 316-323.
11. Pezaro C, James P, McKinley J, Shanahan M, Young MA, Mitchell G. The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause. Fam Cancer 2012;11:403-410.
12. Siri PW, Ginsberg HN. Ovariectomy leads to increased insulin resistance in human apolipoprotein B transgenic mice lacking brown adipose tissue. Metabolism 2003;52:659-661. (Pubitemid 36896297)
13. Azhar S. Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol 2010;6:657-691.
14. Peters JM, Aoyama T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARα and PPARβ: studies using null mice. Biochim Biophys Acta 2003;1632:80-89. (Pubitemid 36628119)
15. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951. (Pubitemid 23342492)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
17. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc 2003;75:469-486.
18. Mandarim-de-Lacerda CA, Fernandes-Santos C, Aguila MB. Image analysis and quantitative morphology. Methods Mol Biol 2010;611:211-225.
19. Souza-Mello V, Gregorio BM, Relvas-Lucas B, da Silva Faria T, Aguila MB, Mandarim-de-Lacerda CA. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice. Pancreas 2011;40:715-722.
20. Frantz ED, Aguila MB, Pinheiro-Mulder AR, Mandarim-de-Lacerda CA. Transgenerational endocrine pancreatic adaptation in mice from maternal protein restriction in utero. Mech Ageing Dev 2011;132:110-116.
21. Chang CJ, Wu CH, Yao WJ, Yang YC, Wu JS, Lu FH. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. Int J Obes Relat Metab Disord 2000;24:1699-1704.
22. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009;16:639-643.
23. Marques CM, Nascimento FA, Mandarim-de-Lacerda CA, Aguila MB. Exercise training attenuates cardiovascular adverse remodeling in adult ovariectomized spontaneously hypertensive rats. Menopause 2006;13: 87-95.
24. Kanaya AM, Vittinghoff E, Shlipak MG, et al. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 2003;158:1161-1170. (Pubitemid 37548786)
25. Hong SC, Yoo SW, Cho GJ, et al. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 2007;14:835-840. (Pubitemid 47517580)
26. Rogers NH, Perfield JW II, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009; 150:2161-2168.
27. Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB, Mandarim-de-Lacerda CA. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition 2009;25: 818-827.
28. Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, Barbosa Aguila M, Mandarim-de-Lacerda CA. Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 2009;38:e80-e86.
29. Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of β-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 2005;54:2755-2763. (Pubitemid 41233599)
30. Takeda K, Toda K, Saibara T, et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 2003;176:237-246. (Pubitemid 36284816)
31. Yoshikawa T, Toda K, Nemoto Y, et al. Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration. Hepatol Res 2002;22:278-287. (Pubitemid 34498385)
32. Akamine EH, Marcal AC, Camporez JP, et al. Obesity induced by highfat diet promotes insulin resistance in the ovary. J Endocrinol 2010;206:65-74.
33. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007;15:798-808. (Pubitemid 46740952)
34. Gallou-Kabani C, Vige A, Gross MS, et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 2007;15:1996-2005. (Pubitemid 47402231)
35. Karasawa H, Nagata-Goto S, Takaishi K, Kumagae Y. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice. Metabolism 2009;58:296-303.
36. Fex M, Nitert MD, Wierup N, Sundler F, Ling C, Mulder H. Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet. Diabetologia 2007;50:74-83. (Pubitemid 46035856)
37. Ballian N, Hu M, Liu SH, Brunicardi FC. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans. Pancreas 2007;35: 199-206. (Pubitemid 47482510)
38. Cerf ME. High fat diet modulation of glucose sensing in the A-cell. Med Sci Monit 2007;13:RA12-RA17. (Pubitemid 46045539)
39. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. A-Cell deficit and increased A-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-210.
40. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB. The pancreatic A-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 2009;304:63-68.
41. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009;150:2109-2117.
42. Le May C, Chu K, Hu M, et al. Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 2006;103:9232-9237. (Pubitemid 43902561)
43. Murphy SM, Agrawal H, Sorooshian A, et al. Comprehensive simultaneous shipboard and airborne characterization of exhaust from a modern container ship at sea. Environ Sci Technol 2009;43:4626-4640.
44. Jia D, Yamamoto M, Otani M, Otsuki M. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats. Metabolism 2004;53:405-413. (Pubitemid 38419180)
45. Tenenbaum H, Behar S, Boyko V, et al. Long-term effect of bezafibrate on pancreatic β-cell function and insulin resistance in patients with diabetes. Atherosclerosis 2007;194:265-271. (Pubitemid 47495923)
46. Kouidhi S, Jarboui S, Marrakchi R, et al. Adiponectin expression and metabolic markers in obesity and type 2 diabetes. J Endocrinol Invest 2011;34:e16-e23.
47. Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 2005;153: 409-417. (Pubitemid 41410498)
48. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:2442-2450. (Pubitemid 36993340)
49. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556. (Pubitemid 38766330)
50. Hiuge A, Tenenbaum A, Maeda N, et al. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol 2007;27:635-641.
51. Bonner-Weir S. Regulation of pancreatic β-cell mass in vivo. Recent Prog Horm Res 1994;49:91-104. (Pubitemid 24976622)
52. Kahn SE. Clinical review 135: the importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058. (Pubitemid 32848511)
53. Jia D, Otsuki M. Bezafibrate, a peroxisome proliferator-activated receptor (PPAR)-α activator, prevents pancreatic degeneration in obese and diabetic rats. Pancreas 2003;26:286-291. (Pubitemid 36384162)
54. Marques CM, Motta VF, Torres TS, Aguila MB, Mandarim-de-Lacerda CA. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 2010;43:467-475.
55. Lemay A, Turcot L, Dechene F, Dodin S, Forest JC. Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance. Menopause 2010;17:321-325.
56. Kim Y, Iwashita S, Tamura T, Tokuyama K, Suzuki M. Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. Biochem Biophys Res Commun 1995;208:1092-1098.
57. Reimer MK, Ahren B. Altered β-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 2002;51(suppl 1);S138-S143. (Pubitemid 34761509)
58. Nascimento FA, Barbosa-da-Silva S, Fernandes-Santos C, Mandarim-de-Lacerda CA, Aguila MB. Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n j 3 fatty acid rich oil). Exp Toxicol Pathol 2010; 62:17-25.